A diffractive multifocal design for ocular implant is provided. This ocular implant includes a diffractive multifocal intraocular lens (IOL) and a number of haptics. The diffractive multifocal IOL passes optical energy to distance, intermediate and near foci. The haptics mechanically couple to the diffractive multifocal IOL in order to position and secure the diffractive multifocal IOL within the eye. The diffractive multifocal IOL may include both a diffractive region and a refractive region, the diffractive multifocal IOL operable to phase shift optical energy such that constructive interference occurs within the diffractive region and the refractive region.

Patent
   8652205
Priority
Oct 26 2009
Filed
Oct 22 2010
Issued
Feb 18 2014
Expiry
Oct 22 2030
Assg.orig
Entity
Large
27
74
currently ok
1. An ocular implant, comprising:
a diffractive multifocal intraocular lens (IOL) operable to provide a distance, a near and an intermediate focus, the diffractive multifocal IOL having a thin edge operable to support a smaller incision, wherein the diffractive multifocal IOL comprises a bifocal diffractive region providing only the distance and near foci, a center-distance refractive region and an outer refractive region, the phase of the outer refractive region matching the phase of the bifocal diffractive region and the phase of the center-distance refractive region shifted out of phase from the bifocal diffractive region by between ⅛ and 1/16 of a wave to phase-shift optical energy such that constructive interference between the center-distance refractive region and the bifocal diffractive region occurs at both the distance and intermediate foci; and
a plurality of haptics coupled to the diffractive multifocal IOL operable to position the diffractive multifocal IOL within an eye.
5. A method to correct visual impairment of aphakia comprising:
removing a natural lens from an eye;
inserting a diffractive multifocal intraocular lens (IOL) within the eye, the diffractive multifocal IOL operable to provide a near focus, an intermediate focus and a distance focus, the diffractive multifocal IOL comprises:
a center-distance refractive region,
a central bifocal diffractive region providing only the distance and near foci; and
an outer refractive region, the phase of the outer refractive region matching the phase of the central bifocal diffractive region to phase shift optical energy and the phase of the center-distance refractive region shifted out of phase from the bifocal diffractive region by between ⅛ and 1/16 of a wave such that constructive interference between the center-distance refractive region and the bifocal diffractive region occurs with the central bifocal diffractive region and the refractive region at both the intermediate and the distance foci;
positioning and securing the diffractive multifocal IOL within the eye with a plurality of haptics coupled to the diffractive multifocal IOL.
2. The ocular implant of claim 1, wherein:
the diffractive region is operable to pass optical energy simultaneously to the distance, intermediate and near foci in bright optical conditions; and
the refractive region is operable to pass optical energy to distance vision in dim optical conditions.
3. The ocular implant of claim 1, wherein the diffractive multifocal IOL comprises a biconvex optic.
4. The ocular implant of claim 1, wherein the diffractive region comprises:
a plurality of concentric steps of varying step heights that allocate energy based on lighting conditions and activity to produce a full range (near to distant) of quality vision.
6. The method of claim 5, wherein the diffractive multifocal IOL comprises a biconvex optic.
7. The method of claim 5, wherein the central diffractive region comprises:
a plurality of concentric steps of varying step heights that allocate energy based on lighting conditions and activity to produce a full range (near to distant) of quality vision.

This application claims priority to U.S. Provisional Application Ser. No. 61/254,938 filed on Oct. 26, 2009.

The present invention relates generally to multifocal ophthalmic lenses, and, more particularly, to multifocal intraocular lenses that can provide refractive and diffractive optical focusing powers.

The human eye in its simplest terms functions to provide vision by transmitting light through a clear outer portion called the cornea, and focusing the image by way of a lens onto a retina. The quality of the focused image depends on many factors including the size and shape of the eye, and the transparency of the cornea and lens. Age and/or disease often cause the lens to become less transparent. Thus, vision deteriorates because of the diminished light which can be transmitted to the retina. This deficiency in the lens of the eye is medically known as a cataract.

Intraocular lenses (IOLs) are routinely implanted in patients' eyes during cataract surgery to replace a natural crystalline lens. Some IOLs employ diffractive structures to provide a patient with not only a far-focus power but also a near-focus power. In other words, such multifocal IOLs provide the patient with a degree of accommodation (sometimes referred to as “pseudo-accommodation”). Although patients having such IOLs generally enjoy the versatile focusing properties of these lenses, a small percentage make observations about the quality of their intermediate vision.

Various multifocal ophthalmic lens designs generally fall into one of two categories, refractive lenses and diffractive lenses. Diffractive lenses use nearly periodic microscopic structures on the lens to diffract light into several directions simultaneously. This is similar to a diffraction grating and the multiple diffraction orders focus the light into various images corresponding to different focal lengths of the lens. Diffractive multifocal contact lenses and IOLs are more fully discussed in U.S. Pat. Nos. 4,162,122, 4,210,391, 4,338,005, 4,340,283, 4,995,714, 4,995,715, 4,881,804, 4,881,805, 5,017,000, 5,054,905, 5,056,908, 5,120,120, 5,121,979, 5,121,980, 5,144,483, 5,117,306 (Cohen), U.S. Pat. Nos. 5,076,684, 5,116,111 (Simpson, et al.), U.S. Pat. No. 5,129,718 (Futhey, et al.) and U.S. Pat. Nos. 4,637,697, 4,641,934 and 4,655,565 (Freeman), the entire contents of which are incorporated herein by reference.

While a diffractive IOL may have a number of focal lengths, generally, IOLs with only two focal lengths (far and near) are the most common. As with any simultaneous vision multifocal lens, a defocused image (or images) is superimposed on the focused component because of the second lens power, but the defocused image is rarely observed by the user, who concentrates on the detail of interest.

Accordingly, there is a need for enhanced ophthalmic lenses for correcting vision, and more particularly, for such lenses that can be employed to compensate for the lost optical power of a removed natural lens. In particular, a need exists for an IOL with the ability to restore vision across a range of object distances following removal of a natural lens.

Embodiments of the present disclosure provide an improved diffractive multifocal design for ocular implant. This ocular implant includes a diffractive multifocal intraocular lens (IOL) and a number of haptics. The diffractive multifocal IOL passes optical energy in distance, intermediate and near conditions. The haptics mechanically couple to the diffractive multifocal IOL in order to position and secure the diffractive multifocal IOL within the eye. The diffractive multifocal IOL may include both a diffractive region and a refractive region. The diffractive region may be a central region or optic zone of the lens that includes concentric steps of gradually varying step heights in order to allocate energy based on lighting conditions and activity in order to create a full range of quality vision, i.e. near, intermediate and distant for the patient. This allows conditions where the natural lens of the eye must be replaced to be corrected.

Other embodiments of the present disclosure provide a method to correct for visual impairment of aphakia. In one embodiment this involves removing a natural lens from an eye when the lens may be diseased or damaged through accident. Next a diffractive multifocal IOL may be inserted within the eye and then secured and positioned with a number of haptics. The diffractive region of the diffractive multifocal IOL may simultaneously pass optical energy to distant, intermediate and near focal points in bright optical conditions while the outer refractive region may pass optical energy to distance vision in dim optical conditions. Yet another embodiment of the present disclosure provides a method to correct visual impairment. This method involves passing optical energy to the retina wherein the optical energy may be imaged. This optical energy is passed with a diffractive multifocal IOL typically located within the eye and used to replace the natural lens. The diffractive multifocal IOL passes optical energy in distance, intermediate and near conditions. The diffractive multifocal IOL can have a central diffractive region and an outer refractive region.

Embodiments of the present disclosure allow patients having visual impairment to have clear distance vision at smaller pupil conditions, i.e. photopic conditions, and have improved vision at larger pupil, i.e. mesopic conditions.

Other advantages of the present disclosure will become more apparent to one skilled in the art upon reading and understanding the detailed description of the preferred embodiments described herein with reference to the following drawings.

For a more complete understanding of the present disclosure and the advantages thereof, reference is now made to the following description taken in conjunction with the accompanying drawings in which like reference numerals indicate like features and wherein:

FIG. 1 illustrates the anatomy of the eye in which depicts an diffractive IOL in accordance with embodiments of the present disclosure may be placed;

FIG. 2 depicts a diffractive IOL in accordance with embodiments of the present disclosure;

FIG. 3 provides a cross section 300 of a diffractive multifocal ophthalmic lens characterized by a plurality of annular zones depicts in accordance with embodiments of the present disclosure;

FIG. 4 provides a top down view of a radially segmented diffractive multifocal ophthalmic lens characterized by a plurality of annular zones depicts in accordance with embodiments of the present disclosure;

FIGS. 5A-5H provide graph depicting the results associated with shifting initial phase to redistribute energy between near, intermediate and distant for a 3 mm IOL in accordance embodiments of the present disclosure; and

FIG. 6 provides a logic flow diagram of a method to correct for visual impairments such as aphakia of the eye.

Preferred embodiments of the present disclosure are illustrated in the FIGs., like numerals being used to refer to like and corresponding parts of the various drawings.

An improved diffractive multifocal design for ocular implant is provided. This ocular implant includes a diffractive multifocal intraocular lens (IOL) and a number of haptics. The diffractive multifocal IOL passes optical energy in distance, intermediate and near conditions. The haptics mechanically couple to the diffractive multifocal IOL in order to position and secure the diffractive multifocal IOL within the eye. The diffractive multifocal IOL may include both a diffractive region and a refractive region, the diffractive multifocal IOL operable to phase shift optical energy such that constructive interference occurs within the diffractive region and the refractive region.

Sight is, by far, one of our most valuable senses. Without our vision, everyday tasks like driving and reading books would be impossible. Our eyes are complex machines that deliver a clear picture of the world around us—communicating the simplest of colors, shapes and textures. FIG. 1 illustrates the anatomy of the eye into which the improved diffractive multifocal design for ocular implant provided by the present disclosure may be placed. Eye 100 includes cornea 102, iris 104, pupil 106, lens 108, lens capsule 110, zonules, ciliary body, sclera 112, vitreous gel 114, retina 116, macula, and optic nerve 120. Cornea 102 is a clear, dome-shaped structure on the surface of the eye acts as a window, letting light into the eye. Iris 104 is the colored part of the eye, called the iris, is a muscle surrounding the pupil that relaxes and contracts to control the amount of light entering the eye. Pupil 106 is the round, central opening of the iris. Lens 108 is the structure inside the eye that helps to focus light on the retina. Lens capsule 110 is an elastic bag that envelops the lens, helping to control lens shape when the eye focuses on objects at different distances. Zonules are slender ligaments that attach the lens capsule to the inside of the eye, holding the lens in place. The Ciliary body is the muscular area attached to the lens that contracts and relaxes to control the size of the lens for focusing. Sclera 112 is the tough, outermost layer of the eye that maintains the shape of the eye. Vitreous gel 114 is the large, gel-filled section that is located towards the back of the eyeball, and which helps to maintain the curvature of the eye. Retina 116 is a light-sensitive nerve layer in the back of the eye that receives light and converts it into signals to send to the brain. The macula is the area in the back of the eye that contains functions for seeing fine detail. Optic nerve 118 connects and transmits signals from the eye to the brain.

FIG. 2 depicts a diffractive IOL in accordance with embodiments of the present disclosure. Diffractive Optic IOL 200 provided is an artificial lens implanted in the eye to restore vision after a natural lens has been removed. The need for the IOL may be due to cataract, disease or accidents. The lens of the IOL may be convex on both sides (biconvex) and made of a soft plastic that can be folded prior to insertion, allowing placement through an incision smaller than the optic diameter of the lens. After surgical insertion into the eye, the lens gently unfolds to restore vision. The supporting arms (haptics) 202 provide for proper positioning of the IOL within the eye.

Diffractive Optic IOL 200 may be positioned in the posterior chamber of the eye, replacing the natural lens. This position allows Diffractive Optic IOL 200 to correct the visual impairment of aphakia (absence of the natural lens). Diffractive Optic IOL 200 may have a biconvex optic that is shaped using a process called apodized diffraction to provide increased depth of focus. The Diffractive Optic IOL 200 may be used in adult patients with and without presbyopia, who desire near, intermediate and distance vision with increased independence from glasses following cataract surgery. Diffractive Optic IOL 200 provides good near, intermediate and distance vision with increased independence from glasses in patients who have undergone cataract surgery. Diffractive Optic IOL 2 delivers quality vision for various lighting situations. In brightly lit conditions, the central diffractive portion 204 sends light waves simultaneously to distant, intermediate and near focal points, while, in dimly lit conditions, the surrounding refractive area 206 sends greater energy to distance vision.

FIG. 3 provides a cross section 300 of a diffractive multifocal ophthalmic lens characterized by a plurality of annular zones depicts in accordance with embodiments of the present disclosure. Embodiments provides for phase-shifting between the plurality of annular zones to enhance the distance vision and maintain good intermediate vision. The amount of phase shift may be carefully optimized to have the constructive interference between the center-distance refractive region and the diffractive region. As the consequences, the distance vision is augmented and the intermediate vision is extended. In specifics, the initial phase of the center-distance region is adjusted to match the surrounding diffractive structure so that the constructive interference occurs at the distance focus and intermediate foci. Shifting initial phase upwards redistributes energy from near to intermediate and shifting downwards redistributes from distance to intermediate. A good balance is achieved in one embodiment when shifting initial phase to 1/16 of a wave. This design maintains good distance, intermediate and near focus. Further optimization may result in other modified designs.

The process for determining these annular zones is described in U.S. Pat. No. 5,699,142 (Lee et al.), the entire contents of which are incorporated herein by reference. The boundary of each zone with respect to the optical axis is calculated. Steps 302 are placed at the radial zone boundaries between the various individual echelettes. Progressively reducing the step height of a selected group of individual echelettes 304 by a predetermined amount can reduce the unwanted effects of glare perceived as a halo or rings around a distant, discrete light source. The selected group of individual echelettes to be reduced in step height is all contained in what is termed an apodization zone.

Note that the step height of the echelettes 304 surrounding the optical axis (OA) remains constant over several echelettes 304 before beginning to reduce in size. Then, as the distance of each individual echelette from the optical axis OA increases the step height of each echelette 304 approaches zero. In other embodiments the height of the echelettes 304 surrounding the optical axis OA begins diminishing with the increase in the distance of the echelette 304 from the optical axis OA. These echettes may be further radially segmented as shown in FIG. 4.

FIG. 4 provides a top down view of a radially segmented diffractive multifocal ophthalmic lens characterized by a plurality of annular zones depicts in accordance with embodiments of the present disclosure. radially segmented diffractive multifocal ophthalmic lens 400 includes haptics 402, which further include gusset 416, elbow 418 and distal portion 420 having widened portion 422; optic 410 which includes central radially apodized diffractive portion 404 having radially segmented zones 424 and a surrounding refractive area 406 In one embodiment thickness of elbow 418 and distal portion 420 of haptic 402 is uniform, and preferably between about 0.30 mm and 0.60 mm, with between about 0.40 mm and 0.50 mm being more preferred and about 0.43 being most preferred. Gusset 416, however, has a thickness that is reduced toward anterior side 212 of the optic. Gusset 416 preferably is between about 0.15 mm and 0.60 mm thick, with between about 0.25 mm and 0.35 mm thick being more preferred and about 0.30 mm being most preferred. This reduced thickness generally extends from edge 208 of the optic. The relatively thin cross section of gusset 416 and edge 308 provides a thinner profile when IOL 400 is inserted through the surgical incision. The reduced thickness of gusset 416 also facilitates fluid circulation (e.g., viscoelastic) between posterior side 214 and anterior side 212 of IOL. Alternatively, gusset 416 or optic 410 may be provided with other means (such as holes, grooves, notches, micro-fenestration, or protuberances (all not shown)) to facilitate fluid flow between posterior side 214 and anterior side 212 of the IOL. The relatively long length and radius of distal portion 420 provides greater contact with the capsular bag for better fixation when IOL 400 is implanted in the eye. Elbow 418 creates a hinge that allows haptic 402 to flex while minimizing buckling and vaulting of optic 410. Widened portion 422 increases the stiffness of haptic 402 just past elbow 418, thereby increasing the strength of haptic 402 at a critical stress point.

Embodiments of the present disclosure provide an improved apodized multi-focal design for an ocular implant, such as, intraocular lens (IOL) that utilizes a profile to provide improved distance vision for smaller pupils, such as photopic conditions, and improved near vision at larger pupils compared to previously available apodized diffractive multi-focal lenses.

Some patients need clearer distance vision at smaller pupil, that is, at photopic condition. Likewise, some patients require better vision at larger pupil, that is, at mesopic condition. For example, some patients have difficulty reading menus in restaurants with dim light where the pupil could be 4 mm or larger. Embodiments of the present disclosure utilize the energy distribution of a multi-focal design and are optimized to achieve higher energy for distance vision at 2.75 mm or smaller pupils. At the same time, it achieves higher energy for near vision compared to previously available ocular implants at 3.5 mm or larger pupil.

Embodiments also provide other features of an ocular implant of that include a thin edge for aiding in smaller incision during the implantation surgery; an about 5 to 10% or greater improvement in MTF values at 2 and 2.5 mm or smaller pupil as compare to previously available apodized multi-focal designs; and an about 15% or higher improvement in MTF values at 3.5 mm or larger pupil for near vision as compare to previously available apodized multi-focal designs. The 5 to 10% or greater improvement for smaller pupils allows for better distance vision at photopic conditions. Similarly the 15% improvement for larger pupils allows for improved near vision at mesopic or dim light condition. Embodiments of the present disclosure have demonstrated that one can reduce the energy to near, and use a larger lens region that directs light to near while providing good visual performance. Embodiments may optimize the area for design improvements that allow for better vision at all lighting conditions, such as, photopic and mesopic conditions for certain pupils. Visual disturbances will not be increased at night within some embodiments of the present disclosure.

FIGS. 5A-5H provide graph depicting the results associated with shifting initial phase to redistribute energy between near, intermediate and distant for a 3 mm IOL in accordance embodiments of the present disclosure. Embodiments provides for phase-shifting within a combination of diffractive optics to enhance the distance vision and maintain good intermediate vision. The amount of phase shift may be carefully optimized to have the constructive interference between the center-distance refractive region and the diffractive region. As the consequences, the distance vision is augmented and the intermediate vision is extended. In specifics, the initial phase of the center-distance region is adjusted to match the surrounding diffractive structure so that the constructive interference occurs at the distance focus and intermediate foci. Shifting initial phase upwards redistributes energy from near to intermediate and shifting downwards redistributes from distance to intermediate. A good balance is achieved in one embodiment when shifting initial phase to 1/16 of a wave. This design maintains good distance, intermediate and near focus. In FIGS. 5A and 5B the DD distance-center is shifted upwards by ⅛ waves. In FIGS. 5C and 5D the DD distance-center is shifted downwards by ⅛ waves. In FIGS. 5E and 5F the DD distance-center is unshifted. In FIGS. 5G and 5H the DD distance-center is shifted downwards by 1/16 of a wave. Further optimization may result in other modified designs.

As shown in these FIGs., embodiments of the present disclosure may provide clearer distance vision at smaller pupil, that is, at photopic condition and better vision at larger pupil, that is, at mesopic conditions.

FIG. 6 provides a logic flow diagram of a method to correct for visual impairments such as aphakia of the eye. Operations 600 begin with the removal of a natural lens from an eye in Step 602. An apodized diffractive multi-focal IOL may then be inserted within the eye. The lenses of the diffractive multi-focal IOL may be convex on both sides (bi-convex) and made of a soft plastic that can be folded prior to insertion. This folding allows placement through a reduced-size incision wherein the incision is smaller than the optic diameter of the diffractive multi-focal IOL. After surgical insertion into the eye in step 604 the IOL may gently unfold to restore vision. In Step 606, the IOL is positioned and secured within the eye. This may be done with the use of supporting arms (haptics) to provide for proper positioning of the IOL within the eye. Embodiments of the present disclosure may place or position the IOL in posterior chamber of the eye to replace the natural lens as shown in FIG. 1. This position allows the IOL to correct visual impairments such as the absence of a natural lens whether through disease or accident. The lens itself may be a diffractive multi-focal IOL as discussed previously. This allows patients with and without presbyopia who desire near intermediate and distant vision to experience independence from glasses following surgery such as cataract surgery.

In summary, embodiments of the present disclosure provide an improved diffractive multifocal design for ocular implant. This ocular implant includes a diffractive multifocal intraocular lens (IOL) and a number of haptics. The diffractive multifocal IOL passes optical energy in distance, intermediate and near conditions. The haptics mechanically couple to the diffractive multifocal IOL in order to position and secure the diffractive multifocal IOL within the eye. The diffractive multifocal IOL may include both a diffractive region and a refractive region. The diffractive region may be a central region or optic zone of the lens that includes concentric steps of gradually varying step heights in order to allocate energy based on lighting conditions and activity in order to create a full range of quality vision, i.e. near to distant or the patient. This allows conditions where the natural lens of the eye must be replaced to be corrected.

Other embodiments of the present disclosure provide a method to correct for visual impairment of aphakia. In one embodiment this involves removing a natural lens from an eye when the lens may be diseased or damaged through accident. Next a diffractive multifocal IOL may be inserted within the eye and then secured and positioned with a number of haptics. The diffractive region of the diffractive multifocal IOL may simultaneously pass optical energy to distant, intermediate and near focal points in bright optical conditions while the outer refractive region may pass optical energy to distance vision in dim optical conditions. Yet another embodiment of the present disclosure provides a method to correct visual impairment. This method involves passing optical energy to the retina wherein the optical energy may be imaged. This optical energy is passed with a diffractive multifocal IOL typically located within the eye and used to replace the natural lens. The diffractive multifocal IOL passes optical energy in distance, intermediate and near conditions. The diffractive multifocal IOL can have a central diffractive region and an outer refractive region.

Embodiments of the present disclosure allow patients having visual impairment to have clear distance vision at smaller pupil conditions, i.e. photopic conditions, and have improved vision at larger pupil, i.e. mesopic conditions.

As one of average skill in the art will appreciate, the term “substantially” or “approximately”, as may be used herein, provides an industry-accepted tolerance to its corresponding term. As one of average skill in the art will further appreciate, the term “operably coupled”, as may be used herein, includes direct coupling and indirect coupling via another component, element, circuit, or module. As one of average skill in the art will also appreciate, inferred coupling (i.e., where one element is coupled to another element by inference) includes direct and indirect coupling between two elements in the same manner as “operably coupled”. As one of average skill in the art will further appreciate, the term “compares favorably”, as may be used herein, indicates that a comparison between two or more elements, items, signals, etc., provides a desired relationship.

Although the present disclosure is described in detail, it should be understood that various changes, substitutions and alterations can be made hereto without departing from the spirit and scope of the disclosure as described by the appended claims.

Hong, Xin, Karakelle, Mutlu, Zhang, Xioaxioa

Patent Priority Assignee Title
10203522, Apr 05 2012 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
10209535, Apr 05 2012 Brien Holden Vision Institute Lenses, devices and methods for ocular refractive error
10466507, Apr 05 2012 Brien Holden Vision Institute Limited Lenses, devices and methods for ocular refractive error
10520754, Oct 17 2012 Brien Holden Vision Institute Limited Lenses, devices, systems and methods for refractive error
10534198, Oct 17 2012 Brien Holden Vision Institute Limited Lenses, devices, methods and systems for refractive error
10838235, Apr 05 2012 Brien Holden Vision Institute Limited Lenses, devices, and methods for ocular refractive error
10948743, Apr 05 2012 Brien Holden Vision Institute Limited Lenses, devices, methods and systems for refractive error
11022815, Aug 31 2012 AMO GRONINGEN B.V. Multi-ring lens, systems and methods for extended depth of focus
11129707, Aug 12 2015 PHYSIOL S A Trifocal intraocular lens with extended range of vision and correction of longitudinal chromatic aberration
11156853, Jun 28 2017 AMO GRONINGEN B.V. Extended range and related intraocular lenses for presbyopia treatment
11262598, Jun 28 2017 AMO Groningen, B.V. Diffractive lenses and related intraocular lenses for presbyopia treatment
11320672, Oct 07 2012 Brien Holden Vision Institute Limited Lenses, devices, systems and methods for refractive error
11327210, Jun 30 2017 AMO GRONINGEN B.V. Non-repeating echelettes and related intraocular lenses for presbyopia treatment
11333903, Oct 17 2012 Brien Holden Vision Institute Limited Lenses, devices, methods and systems for refractive error
11497599, Mar 17 2017 AMO GRONINGEN B.V. Diffractive intraocular lenses for extended range of vision
11523897, Jun 23 2017 AMO GRONINGEN B.V. Intraocular lenses for presbyopia treatment
11573433, Jun 28 2017 AMO GRONINGEN B.V. Extended range and related intraocular lenses for presbyopia treatment
11644688, Apr 05 2012 Brien Holden Vision Institute Limited Lenses, devices and methods for ocular refractive error
11809024, Apr 05 2012 Brien Holden Vision Institute Limited Lenses, devices, methods and systems for refractive error
11844689, Dec 30 2019 AMO GRONINGEN B V Achromatic lenses and lenses having diffractive profiles with irregular width for vision treatment
11914229, Jun 28 2017 AMO GRONINGEN B.V. Diffractive lenses and related intraocular lenses for presbyopia treatment
9195074, Apr 05 2012 Brien Holden Vision Institute Lenses, devices and methods for ocular refractive error
9201250, Oct 17 2012 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
9535263, Apr 05 2012 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
9541773, Oct 17 2012 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
9575334, Apr 05 2012 Brien Holden Vision Institute Lenses, devices and methods of ocular refractive error
9759930, Oct 17 2012 Brien Holden Vision Institute Lenses, devices, systems and methods for refractive error
Patent Priority Assignee Title
4162122, Sep 14 1977 Zonal bifocal contact lens
4210391, Sep 14 1977 Multifocal zone plate
4338005, Dec 18 1978 Multifocal phase place
4340283, Dec 18 1978 Phase shift multifocal zone plate
4637697, Oct 27 1982 Novartis AG Multifocal contact lenses utilizing diffraction and refraction
4641934, Apr 14 1982 Novartis AG Ophthalmic lens with diffractive power
4642112, Apr 29 1981 Novartis AG Artificial eye lenses
4655565, Apr 14 1982 Novartis AG Ophthalmic lenses with diffractive power
4881804, Nov 12 1987 Multifocal phase plate with a pure refractive portion
4881805, Nov 12 1987 Progressive intensity phase bifocal
4888012, Jan 14 1988 Intraocular lens assemblies
4995714, Aug 26 1988 CooperVision International Holding Company, LP Multifocal optical device with novel phase zone plate and method for making
4995715, May 14 1986 Coopervision, Inc Diffractive multifocal optical device
5017000, May 14 1986 Multifocals using phase shifting
5054905, Nov 12 1987 Progressive intensity phase bifocal
5056908, Nov 12 1987 Optic zone phase channels
5076684, Apr 01 1988 Minnesota Mining and Manufacturing Company Multi-focal diffractive ophthalmic lenses
5096285, May 14 1990 Iolab Corporation Multifocal multizone diffractive ophthalmic lenses
5116111, Apr 01 1988 Minnesota Mining and Manufacturing Company Multi-focal diffractive ophthalmic lenses
5117306, Jul 17 1990 Diffraction bifocal with adjusted chromaticity
5120120, Jul 27 1990 Multifocal optical device with spurious order suppression and method for manufacture of same
5121979, May 14 1986 COOPERVISION INTERNATIONAL LIMITED Diffractive multifocal optical device
5121980, Apr 19 1989 Small aperture multifocal
5129718, Apr 01 1988 Minnesota Mining and Manufacturing Company Multi-focal diffractive ophthalmic lenses
5144483, May 14 1986 COOPERVISION INTERNATIONAL LIMITED Diffractive multifocal optical device
5217489, Apr 05 1991 Alcon Research, Ltd Bifocal intraocular lens
5257132, Sep 25 1990 UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF ENERGY, THE Broadband diffractive lens or imaging element
5470932, Oct 18 1993 Alcon Research, Ltd Polymerizable yellow dyes and their use in opthalmic lenses
5528322, Oct 18 1993 Alcon Research, Ltd Polymerizable yellow dyes and their use in ophthalmic lenses
5543504, Oct 18 1993 Alcon Research, Ltd Polymerizable yellow dyes and their use in ophthalmic lenses
5662707, Oct 18 1993 Alcon Research, Ltd Polymerizable yellow dyes and their use in ophthalmic lenses
5699142, Sep 01 1994 Alcon Research, Ltd Diffractive multifocal ophthalmic lens
5800532, Jun 06 1995 Scientific Optics, Inc. Asymmetric intraocular lens
5895422, Jun 17 1993 Mixed optics intraocular achromatic lens
6432246, Oct 26 1988 Abbott Medical Optics Inc Fabrication of an intraocular lens
6536899, Jul 14 1999 ACRI TEC GMBH; *ACRI TEC GMBH Multifocal lens exhibiting diffractive and refractive powers
6596026, Nov 27 2000 VOT FUNDING LLC, A DELAWARE LIMITED LIABILITY COMPANY VOT ; VISIONCARE, INC Telescopic intraocular lens
6599317, Sep 17 1999 JOHNSON & JOHNSON SURGICAL VISION, INC Intraocular lens with a translational zone
6638305, May 15 2001 JOHNSON & JOHNSON SURGICAL VISION, INC Monofocal intraocular lens convertible to multifocal intraocular lens
6685315, Sep 03 1999 Bifocal lenses
6695881, Apr 29 2002 Alcon Inc Accommodative intraocular lens
6800091, Aug 20 1997 THINOPTX, INC Method of using a small incision lens
6923540, Jul 31 2002 Alcon Inc Toric multifocal contact lenses
6951391, Jun 16 2003 APOLLO OPTICAL SYSTEMS, INC Bifocal multiorder diffractive lenses for vision correction
6969403, Apr 29 2002 Alcon Inc Accommodative intraocular lens
7073906, May 12 2005 VISION ADVANCEMENT LLC Aspherical diffractive ophthalmic lens
7150760, Mar 22 2004 Alcon Inc Accommodative intraocular lens system
7156516, Aug 20 2004 APOLLO OPTICAL SYSTEMS, INC Diffractive lenses for vision correction
7188949, Oct 25 2004 JOHNSON & JOHNSON SURGICAL VISION, INC Ophthalmic lens with multiple phase plates
7322695, Mar 27 2006 Johnson & Johnson Vision Care, Inc. Multifocal contact lenses
7350916, Apr 05 2005 Alcon Inc Intraocular lens
7441894, Feb 09 2006 Alcon Inc Pseudo-accommodative IOL having diffractive zones with varying areas
7481532, Feb 09 2006 Alcon Inc Pseudo-accommodative IOL having multiple diffractive patterns
7572007, Aug 02 2006 Alcon Inc Apodized diffractive IOL with frustrated diffractive region
7896916, Nov 29 2002 DWFRITZ AUTOMATION, LLC Multifocal ophthalmic lens
20030014107,
20030065387,
20040252274,
20060066808,
20060116764,
20070171362,
20090088840,
20090187242,
CA2602507,
EP742462,
EP2045648,
WO2006023404,
WO2006047698,
WO2006060480,
WO2010059764,
WO2010144315,
WO2010144317,
WO9744689,
WO9928769,
//////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Oct 22 2010Novartis AG(assignment on the face of the patent)
Nov 11 2010HONG, XINAlcon, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0254300868 pdf
Nov 16 2010ZHANG, XIAOXIAOAlcon, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0254300868 pdf
Nov 29 2010KARAKELLE, MUTLUAlcon, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0254300868 pdf
Apr 08 2011Alcon, IncNovartis AGMERGER SEE DOCUMENT FOR DETAILS 0263760076 pdf
Nov 11 2019Novartis AGAlcon IncCONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 20190514540788 pdf
Date Maintenance Fee Events
Aug 03 2017M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Aug 04 2021M1552: Payment of Maintenance Fee, 8th Year, Large Entity.


Date Maintenance Schedule
Feb 18 20174 years fee payment window open
Aug 18 20176 months grace period start (w surcharge)
Feb 18 2018patent expiry (for year 4)
Feb 18 20202 years to revive unintentionally abandoned end. (for year 4)
Feb 18 20218 years fee payment window open
Aug 18 20216 months grace period start (w surcharge)
Feb 18 2022patent expiry (for year 8)
Feb 18 20242 years to revive unintentionally abandoned end. (for year 8)
Feb 18 202512 years fee payment window open
Aug 18 20256 months grace period start (w surcharge)
Feb 18 2026patent expiry (for year 12)
Feb 18 20282 years to revive unintentionally abandoned end. (for year 12)